Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App





Mobile Mini-Laboratory System Identifies SARS-CoV-2 Virus in 40 Minutes and Conducts 60 Tests per Day

By LabMedica International staff writers
Posted on 18 Nov 2020
A new mini-laboratory system can identify the SARS-CoV-2 virus within roughly 40 minutes and makes it possible to conduct up to 60 tests a day right on the spot where samples are taken.

Spindiag GmbH (Freiburg, Germany) is launching the coronavirus rapid test system that can identify the SARS-CoV-2 virus within roughly 40 minutes. More...
To identify the coronavirus, Spindiag has redesigned a test principle of its own conception which has already worked for antibiotic-resistant bugs. At the heart of this mobile mini-laboratory is a roughly one centimeter thick, crescent-shaped cartridge, with an integrated swab. Nurses and caregivers can use it to take smear tests, for instance from a patient’s nose or throat. They can then push the swab back into the cartridge and place it in an analytical instrument that automatically analyzes the swab and displays the test result. This makes it possible to conduct up to 60 tests a day with a mini-laboratory right on the spot where the samples are taken.

Spindiag’s test process is polymerase chain reaction (PCR)-based. Using PCR, the virus’ genome is replicated sufficiently to be identified even if there are only small quantities in a sample. Spindiag will first introduce its new coronavirus rapid test in Germany and then in all other European Union countries.

Related Links:
Spindiag GmbH


Gold Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Online QC Software
Acusera 24•7
Automatic CLIA Analyzer
Shine i6000
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A new study identifies distinct metabolomic signatures in maternal blood associated with both the timing and type of early birth (Image credit: iStock)

Maternal Blood Biomarkers Identify Risk of Preterm and Early-Term Birth

Preterm and early-term births can lead to lasting complications because vital organs continue to mature during the final weeks of pregnancy. Babies born too soon face increased risks of breathing difficulties,... Read more

Molecular Diagnostics

view channel
Image: Spatial profiling of muscle-invasive bladder cancer reveals how distinct tumor cell states are organized within individual tumors (Image Credit: Shutterstock)

Spatial Map Guides Treatment Selection in Muscle-Invasive Bladder Cancer

Muscle-invasive bladder cancer is clinically heterogeneous, with patients often responding very differently to therapy. Existing biomarkers do not fully explain these disparities, limiting precision treatment... Read more

Microbiology

view channel
Image: Burkholderia pseudomallei is a soil-dwelling bacterium that causes melioidosis, a severe and potentially fatal infection that remains difficult to diagnose (Image Credit: Gavin Koh/Wikimedia Commons, CC BY-SA 4.0)

Stronger Laboratory Services Support Timely Melioidosis Diagnosis Amid Global Spread

Melioidosis, a potentially fatal infection caused by Burkholderia pseudomallei, remains difficult to recognize because its symptoms can mimic tuberculosis and other illnesses. The disease is considered... Read more

Industry

view channel
Image

QIAGEN Enhances QIAcuity Platform with Gene Expression and Multiplexing Tools

QIAGEN (Venlo, Netherlands) has introduced additions to its QIAcuity dPCR ecosystem that focus on gene expression, expanded assay content, and workflow standardization for life sciences and biopharma users.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.